Renal cell carcinoma with prominent smooth muscle stroma is a rare neoplasm composed of an admixture of epithelial cell with clear cytoplasm arranged in small nest and tubular structures and a stroma composed of smooth muscle. In the epithelial component, loss of chromosome 3p detected by fluorescence in situ hybridization (FISH) has been reported and on this basis these neoplasms have been viewed as variants of clear cell renal cell carcinoma. To test the validity of this classification, we have evaluated the chromosome 3 and VHL status of three of these tumors using FISH, array comparative genomic hybridization, gene sequencing, and methylation-specific multiplex ligation-dependent probe amplification analysis. None of the tumors showed deletion of chromosome 3p, VHL mutation, a significant VHL methylation, or changes in VHL copy number and all three tumors demonstrated a flat profile in the comparative genomic hybridization analysis. We conclude that renal cell carcinoma with smooth muscle stroma should be considered as an entity distinct from clear cell renal cell carcinoma.
In 2006, Kuhn et al 1 described five cases of what appeared to be clear cell renal cell carcinoma, Fuhrman grade 2, associated with a peculiar stromal proliferation having angioleiomyoma-like features which were particularly prominent at the interphase between the edge of the tumor and the surrounding renal parenchyma. They postulated that the angioleiomyoma-like change is an epiphenomenon caused by the overproduction of hypoxia-inducible factor, vascular endothelial growth factor, and other growth factors by the neoplastic epithelial cells in which the inactivation of the Von Hippel-Lindau gene (VHL) located on the short arm of the chromosome 3 had occurred. 1 Loss of heterozygosity of chromosome 3p has been frequently shown in both sporadic and hereditary clear cell renal cell carcinomas 2, 3 and the VHL gene has been found to be inactivated by several mechanisms, including deletions and abnormal DNA methylation. [4] [5] [6] Several other recurrent copy number changes, such as gains of 5q, have been reported in clear cell renal cell carcinomas. [7] [8] [9] In 2009, Shannon et al 10 described three more of these tumors and found that they were extensively positive for cytokeratin 7 by immunohistochemistry. They also performed fluorescence in situ hybridization (FISH) analysis of chromosome 3 and found loss of the entire chromosome in two tumors and loss of 3p in the third case. They concluded that these neoplasms are low-grade variants of clear cell renal cell carcinoma, which have induced a metaplastic stromal reaction. 10 In this study, we evaluated the morphological, immunohistochemical, and molecular features of three additional examples of these tumors, focusing on the status of chromosome 3p and the VHL gene using FISH, methylation-specific multiplex ligationdependent probe amplification analysis, and sequencing analyses of the entire VHL gene. In addition, chromosomal copy number changes were analyzed using array comparative genomic hybridization to examine genome-wide changes and exclude the presence of recurrent copy number changes, such as losses of 3p and 5q gains, which are known to occur frequently in clear cell renal cell carcinoma.
Materials and methods

Patient Recruitment
Three renal cell carcinomas with smooth muscle stroma were recruited from the kidney tumor database of the Department of Pathology, University of Verona (GM) on the basis of their morphological features. From 2 to 5 paraffin-embedded blocks per case were available. Sections of 3-mm thick were cut from tissue blocks and stained with hematoxylin and eosin and reviewed by three pathologists (GM, MB, and SG).
Immunohistochemical Analysis
The immunohistochemical profile was investigated using a panel of antibodies including: CD10 (Novacastra, Burlingame, CA, USA; clone 56C6; 1:10 dilution); cytokeratin 7 (Biogenex, Fremont, CA, USA; clone OV-TL 12/30; 1:400 dilution); cytokeratin 5 (Novacastra; clone XM26; 1:100 dilution); cytokeratin 34bE12 (Dako, Carpinteria, CA, USA; clone 34bE12; 1:40 dilution); cytokeratin AE1/AE3 (Dako; clone AE1/AE3; 1:100); parvalbumin (Sigma Chemical Company, St Louis, MO, USA; clone P19; 1:400 dilution); SLC2A1 (GLUT1) (Dako; polyclonal, rabbit; 1:100 dilution); vimentin (Biogenex; clone V9; 1:50 dilution); alpha-methylacyl-CoA racemase (P504S) (Dako; clone 13H7; 1:50 dilution); S100A1 (Dako; clone S100A1/1; 1:50 dilution); desmin (Dako; clone D33; 1:500 dilution); a-smooth muscle actin (Dako; clone 1A4; 1:250 dilution); caldesmon (Dako; clone h-CD); androgen receptor (Dako; clone AR441; 1:20 dilution); estrogen receptor (Dako; 1:20 dilution), progesterone receptor (Dako; clone PgR 636; 1:20 dilution); HMB45 (Dako; clone HMB45; 1:300 dilution) and cathepsin K (Abcam, Cambridge, UK; clone 3F9; 1:2000 dilution). Immunoreactions were developed using a non-biotin, highly sensitive system (Envision peroxidase detection system, Dako) preventing possible false-positive staining owing to endogenous biotin present in the tissue.
Normal renal parenchyma adjacent to the tumors was used as a control.
Array Comparative Genomic Hybridization and Data Analysis
Microdissection from the three formalin-fixed paraffin-embedded kidney tumors was performed manually, with accurate attention in obtaining material from the epithelial zones of tissue slides.
Genomic DNA was isolated using the QIAamp DNA mini kit (Qiagen Nordic, Finland) and quantified on the NanoDrop spectrophotometer (NanoDrop Technologies Inc, DE, USA). As a reference, we used DNA from pooled peripheral blood leukocytes of healthy males. Using the Agilent Human 244K array format containing B240 000 oligonucleotide probes, covering both coding and non-coding genome regions (Agilent Technologies, Santa Clara, CA, USA), we screened copy number alterations in all three tumors. Briefly, 1.5 mg of tumor and reference DNA were digested, labelled, and hybridized according to the Agilent protocols. The array images obtained after scanning (Agilent scanner G2565BA) were processed with the Feature Extraction software (version 10.5), and the output data files were analyzed with the Agilent Genomic Workbench. To identify copy number alterations, we used aberration detection method 2 (ADM-2) algorithm and to exclude the small variances in the data, we set up a custom aberration filter identifying alterations in copy number if a minimum of eight probes gained or lost were identified and with a minimum absolute average log ratio for the region being 0.5. Regions with small copy number variations were excluded by comparing and visualizing the copy number variant regions tool of the Genomic Workbench software.
Fluorescence in situ Hybridization
FISH analysis was performed using a centromericspecific probe for the chromosome 3 centromere (SpectrumGreen CEP3; Abbott) and a subtelomeric probe for 3p25 (SpectrumGreen 3p-LSI; Abbott) to evaluate 3p deletion. From the whole-tissue sections, 3-mm sections were cut from paraffin-embedded blocks. The paraffin was removed from the sections with two 10-min washes with xylene. After hydrating in 100, 85, and 70% ethanol solutions (10 min), rinsing in distilled water (10 min), and twice in phosphate-buffered solution (pH 7, 10 min each), the slides were fixed in methanol-acetic acid 3:1 for 10 min and air-dried. Next, the sections were treated in a 2 XSSC (standard saline citrate) solution for 15 min at 37 1C, and then dehydrated in consecutive 70, 85, and 100% ethanol solutions for 1 min each and then dried. Next, the sections were bathed in 0.1 mM citric acid (pH 6) solution at 85 1C for 1 h. Then, they were again dehydrated in a series of ethanol solutions and dried. The tissue was digested by applying 0.75 ml of pepsin (Sigma) solution (4 mg/ml in 0.9% NaCl, pH 1.5) to each slide and incubating them in a humidified box for 30 min at 37 1C. Next, the slides were rinsed with distilled water for a few seconds, dehydrated again in graded ethanol solutions, and dried. Centromeric probes for chromosomes 3 and the locus-specific sub-telomeric probe 3p were used. Each probe was diluted 1:20 in t-DenHyb-2 buffer (LiStar-FISH, Milan, Italy). Ten microliters of diluted probe was applied to each slide and coverslips were placed over the slides. Denaturation was achieved by incubating the slides at 80 1C for 10 min in a humidified box, and then hybridization was carried out at 37 1C for 16 h. The coverslips were later removed and the slides were immersed at room temperature in 0.5 XSSC for 2 min, in 50% formamide/1 XSSC for 5 min, and in 2 XSSC for 2 min. The slides were air-dried and counterstained with 10 ml of DAPI/Antifade (DAPI in Fluorguard, 0.5 mg/ml; Insitus). The slides were examined using an Olympus BIX-61 microscope (Olympus, Hamburg, Germany) with filters for SpectrumGreen, and the UV Filter for the DAPI nuclear counterstain. The signals were recorded with a CCD camera (Olympus Digital Camera). Fluorescent signals were evaluated as reported previously. [11] [12] [13] Signals from 100 to 200 nuclei were counted, focusing only on neoplastic nuclei from the epithelial components. The control distribution of signals was assessed on non-neoplastic renal parenchyma adjacent to the tumors. The value of the ratio (3p/3) of the normal renal parenchyma þ 3s.d. set to 1.03 þ 3s.d. 0.05 ¼ 1.19. þ 3s.d. was used for each fluorescent score number.
VHL Sequencing Analysis
Five 10-mm thick sections of tumor tissue were cut from formalin-fixed paraffin-embedded blocks. Epithelial and smooth muscle components were separated by manual microdissection. DNA was extracted separately from each component. PCR for the VHL gene analysis was performed using primer sequences from the literature. 14, 15 Normal tissues of the same patients were used as a reference. The reaction conditions were as follows: 12.5 ml of HotStart Taq PCR Master Mix (QIAgen, Hilden, Germany), 10 pmol of each primer, 100 ng of template DNA, and distilled water up to 25 Genomic DNA was isolated from three 5 mM-thick paraffin sections of each renal carcinoma sample using the Ex-Wax DNA Extraction Kit (Chemicon International, Temecula, CA, USA) according to the manufacturer's instructions.
Bidirectional sequencing of PCR products was performed by using an ABI PRISM BigDye terminators v3.1 cycle sequencing kit (Applied Biosystems), and sequences were run on an Applied Biosystems 3130 Genetic Analyzer (Applied Biosystems) and compared with the reference sequence CCDS 2597.1.
The PCR amplicon carrying the mutation was subcloned into a pGEM s -T Easy vector (Promega, Madison, WI, USA), transformed in competent DH5a cells and plated onto LB agar with ampicillin and X-gal selection. Then, 12 distinct blank (white) colonies were picked, plasmid DNA was extracted and submitted to amplification and sequencing of VHL exon 3 as above described.
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification
Microdissection from the three formalin-fixed paraffin-embedded kidney tumors was manually performed, with accurate attention in obtaining material from the epithelial zones of tissue slides.
Genomic DNA extracted from the three samples was subjected to MS-MLPA using ME001-0808-C1 and ME002-0809-B1 probemixes (MRC-Holland, Amsterdam, The Netherlands) with 20-100 ng of DNA per sample. The standard MS-MLPA protocol, which was used here, has been described. 16 Both probemixes contain one specific MLPA probe for the exon 1 of VHL gene that has a recognition site for a CpG methylation-sensitive endonuclease HhaI. The MS-MLPA product fragments were analyzed by ABI model 3130 capillary sequencer (Applied Biosystems, Nieuwerkerk aan den Ijssel, The Netherlands) using Genescan-ROX 500 size standards. As the same probemixes are intended to detect simultaneously both copy number and methylation changes of the target genes, both methylation and copy number status were analyzed using the Coffalyser software (MRC-Holland, Amsterdam, The Netherlands). 17 The data were first normalized by dividing the peak area of a single probe by a cumulative peak area of all control probes (not degraded by HhaI). Then, the normalized peaks from the HhaI digestion reaction were compared with the normalized peaks from the undigested control reaction. Final methylation value for each sample was obtained by subtracting the background methylation values of the control samples (male and female DNA samples; Promega). The following criteria were used for determining the methylation status: 0.00-0.25 (absent), 0.25-0.50 (mild), 0.50-0.75 (moderate), and 40.75 (extensive methylation). For copy number analysis, the following cutoff values were used: o0.7 and 41.3 gain. One DNA sample (labelled 8656) was excluded from the analysis due to the low amount of DNA and for another sample (labelled 10684) we were able to include only results using ME002-0809-B1 probemix as no DNA was available for the further analysis using the ME-001-0808 mix.
Results
Clinical and Pathological Findings
The three patients (all females) were respectively 79, 74, and 74 years old. The tumors presenting a diameter ranging from 2 to 3 cm and were all staged as pT1a N0 M0 (according to AJCC, 2010). Two neoplasms were treated with simple enucleation of the tumor and the third was treated with nephrectomy. All patients were well and alive after 52 months (case 1), 30 months (case 2). and 27 months (case 3).
The three tumors showed similar gross and microscopic features. They were well circumscribed, tan or brownish, somewhat translucent, and surrounded by an irregular pseudocapsule (Figures 1a and b) . One of them showed focal cystic changes. Necrosis was not identified. Histologically, the neoplasms were composed of a mixture of two distinct components (Figures 1c and d) : the epithelial cells with clear cytoplasm and hyperchromatic nuclei (Fuhrman grades 1 and 2), arranged in nests, cords, and small cysts (Figures 1e and f) and a 
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Renal cell carcinoma with smooth muscle stroma stromal proliferation composed of mature smooth muscle cells (Figure 1g ), organized in bundles and merging with the peripheral discontinuous pseudocapsule. The percentage of tumor volume occupied by the stromal component was respectively of 20% (case 1), 40% (case 2), and 30% (case 3). In case 3, there was a large focus of stromal osseous metaplasia (Figure 1h ). Neither necrosis nor mitotic activity was observed in either of the components.
Immunohistochemical Findings
The epithelial component of all three tumors showed diffusely positive reactions with antibodies to cytokeratin 7 (100, 80, and 90% of the cells) (Figure 2a ) and cytokeratin AE1-AE3 (100% of the cells in all three tumors). The reactions with antibody to high molecular weight cytokeratin 34bE12 were positive in all three tumors, with the percentage of positive cells ranging from 10 to 60% (Figure 2b ). The reaction with antibody to carbonic anhydrase IX was positive in two tumors, sometimes showing lack of labelling on the luminal aspect of individual cells (a 'cuplike' staining pattern). All of the tumors gave positive reactions with antibody to SLC2A1 (GLUT1) (Figure 2c ). The reaction for CD10 was focally positive in one tumor, while two tumors gave positive reactions with antibody to S100A1. None of the tumors gave positive reactions for alpha-methylacyl-CoA racemase (P504S), cytokeratin 5, parvalbumin, or vimentin. The reactions with antibodies to progesterone, estrogen and androgen receptors, as well as HMB45 and cathepsin K were also negative.
The stromal component of the tumors showed strong and diffusely positive reactions with antibodies to a-smooth muscle actin (Figure 2d ) and caldesmon (100% of the cells). Antibody to desmin gave a positive reaction only in 30% of the cells in one of the tumors.
Array Comparative Genomic Hybridization Findings
We did not observe any gene copy number abnormalities. A flat profile was observed in each tumor (Table 1; Figure 3 ).
Fluorescence In Situ Hybridization Findings
For chromosomes 3 and the locus-specific subtelomeric chromosome 3p, the percentages of single Locus-specific sub-telomeric 3p probe. Case 1 showed single, double, and three or more fluorescent signals in respectively 39, 60, and 1% of neoplastic epithelial nuclei; case 2 showed single, double, and three or more fluorescent signals in respectively 40, 57, and 3% of neoplastic epithelial nuclei; case 3 showed single, double, and three or more fluorescent signals in respectively 31, 61, and 5% of neoplastic epithelial nuclei.
The value of the ratio on the normal renal parenchyma þ 3s.d set to 1.03 þ 3s.d. 0.05 ¼ 1.19. Renal cell carcinoma with smooth muscle stroma
Ratio was respectively 1.04 in case 1 (not deleted), 1.07 in case 2 (not deleted), and 1.11 in case 3 (not deleted). The details of the FISH analyses are presented in Table 2 .
VHL Gene Mutation
No mutation of the coding sequence of the VHL gene was found in either the epithelial or smooth muscle cell components of any of the tumors (Table 1) .
Methylation-Specific Multiplex Ligation-Dependent Probe Amplification Findings
Methylation-specific ligation-dependent probe amplification analysis of formalin-fixed paraffin-embedded tissue DNA samples showed absent or mild methylation of the VHL gene (Table 3) . In one tumor, it detected a gain of VHL gene copy number (Table 3) .
Discussion
In the three tumors which we studied, we found that deletion of chromosome 3p, VHL mutation, and a significant VHL methylation which are molecular hallmarks of clear cell renal cell carcinoma are lacking in renal cell carcinoma with smooth muscle stroma and that all three tumors demonstrated a flat profile by array comparative genomic hybridization analysis and failed to show recurrent copy number changes such as 5q gains, which have been reported in clear cell renal cell carcinoma. Although the small size of the study precludes any statistical analysis, we conclude on the basis of our observations that these tumors should be considered as a 18 Clear cell renal cell carcinoma typically is positive for cytokeratin 8-18, vimentin, CD10, epithelial membrane antigen, RCC marker, and PAX8 and PAX2 and negative for cytokeratin 7, alpha-methylacyl-CoA racemase (P504S) and cathepsin K. [19] [20] [21] [22] [23] It displays a diffuse membranous staining for carbonic anhydrase IX, 24, 25 reflecting inactivation of the VHL gene and constitutive activation of the hypoxia-inducible factor pathway. A deletion on chromosome arm 3p, where the VHL gene resides, is present in most sporadic and familial clear cell renal cell carcinoma and recently, Nickerson et al 4 identified VHL gene mutations in 82% of clear cell renal cell carcinomas whereas an additional 8% showed hypermethylation in the VHL promoter CpG islands. The VHL gene product, pVHL, regulates transcription of genes through HIF. Normal pVHL targets HIF1-a for degradation in normoxemic states. When the VHL gene is mutated or the pVHL is absent, conditions of hypoxia are simulated and HIF1-a accumulates. HIF1-a activates multiple downstream genes, including vascular endothelial growth factor, the glucose transporter SLC2A1 (GLUT1), and carbonic anhydrase IX. [24] [25] [26] [27] [28] The three cases of renal cell carcinomas with smooth muscle stroma analyzed in this study did not reveal the 3p deletion, nor VHL mutations, nor VHL methylation abnormalities that are frequent in clear cell renal cell carcinomas. Further, all of them demonstrated a flat profile by comparative genomic hybridization analysis and lacked other recurrent copy number changes such as 5q gains which have been reported in clear cell renal cell carcinoma. Therefore, their molecular characters differ from those usually observed in clear cell renal cell carcinomas and from those identified in three similar tumors by Shannon et al. 10 They observed in two tumors the concurrent losses of one signal for VHL and of 3q, used as a control, in B40% of the cells of the epithelial component. They interpreted these results as indicating the loss of one entire chromosome 3. In their third tumor, they found the loss of one signal for VHL, but the retention of both control signals for 3q in B70% of cells and interpreted that to indicate the loss of 3p on just one copy of chromosome 3. We think that the difference between our findings and those previously reported by Shannon et al could be due to the different definitions of monosomy in FISH studies of paraffin sections. Our definition was based both on statistical distribution of double signals for chromosome 3p/3 in the non-neoplastic renal parenchyma adjacent to each of the three tumors and on the results obtained in previous studies.
We observed a variable detection rate of chromosome 3p/3 abnormalities in different series of clear cell renal carcinoma; 3 loss of signals may be either artifactual or biological. A high cutoff level overcomes the artifactual bias (nuclear truncation). Moreover, the absence of any chromosome 3 alteration in our three tumors when investigated by array comparative genomic hybridization confirms our FISH results. By using aCGH analysis, we established a custom aberration filter identifying alterations in copy number if a minimum of eight probes gained or lost were identified, with a minimum absolute average log ratio for the region being 0.5. These cutoffs do not decrease the sensitivity by being too specific, in respect to the 240 000 oligoprobes used in the kits.
In this study, the tumours showed small sizes and a low stage assessment (pT1a) as previously reported. 1 Grossly, they appeared to be different from the yellowish color characteristic of clear cell renal cell carcinomas, being tan or brownish with a somewhat translucent appearance. Moreover, they constantly express diffuse CK7 and frequently express high molecular weight cytokeratin (clone 34bE12) by immunohistochemistry, being markers that are usually negative in clear cell renal cell carcinoma. The absence of immunostaining for HMB45, cathepsin K, estrogen and progesterone receptors both in the clear cell and in the smooth muscle components rule out any relationship between this neoplasm and angiomyolipoma as well as other members of the family of lesions composed by perivascular epithelioid cells (PEComas), MiTF/TFE family renal translocation carcinomas and mixed epithelial-stromal tumors, respectively. 23, [29] [30] [31] Finally, the immunoexpression of cytokeratin 7 in the epithelial component of renal cell carcinoma with smooth muscle stroma and the detection of high molecular weight cytokeratin with antibody clone 34bE12, which are usually undetectable in clear cell renal cell carcinoma, are of interest. These lend support to our conclusion that renal cell carcinoma with smooth muscle stroma is a type of renal cell neoplasm distinct from clear cell renal cell carcinoma. Further, together with our genetic findings, they also suggest that these tumors could be related to clear cell tubulopapillary renal cell carcinoma (and the synonymous or closely related renal angiomyoadenomatous tumor (RAT)), in which smooth muscle metaplasia within intratumoral stroma has been described. [32] [33] [34] [35] [36] [37] [38] [39] [40] Ministero Istruzione, Università e Ricerca. This work has been accepted in part for presentation at the 98nd Annual Meeting of the United States and Canadian Academy of Pathology (USCAP), Boston, MA, 7-13 March 2009.
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